FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3199265287> ?p ?o ?g. }

• W3199265287 endingPage "214" @default.
• W3199265287 startingPage "214" @default.
• W3199265287 abstract "214 Background: Venous thromboembolism (VTE) is a serious and potentially life-threatening complication of surgery. An Enhanced Recovery After Surgery (ERAS) program is a multimodal care pathway meant to facilitate faster recovery from surgery. ERAS protocols include mechanical and pharmacologic VTE prophylaxis and rapid return to ambulation. Our objective was to evaluate the rate of symptomatic VTE on an ERAS pathway among patients undergoing open and minimally invasive gynecologic surgery (MIS). Methods: Data was collected prospectively on patients undergoing gynecologic surgery on the ERAS pathway at a single academic institution between November 1, 2014 and March 31, 2021. For patients undergoing MIS data were collected from February 1, 2016 to March 31, 2021. Patients undergoing emergency surgery or requiring therapeutic anticoagulation prior to surgery were excluded. For planned open surgery, patients received heparin prophylaxis prior to surgery, sequential compression device (SCD) during surgery and goal directed fluid management. If also diagnosed with malignancy, patients received extended VTE prophylaxis with low molecular weight heparin for 28 days after surgery starting postoperative day 1. For planned MIS, patients received SCD and goal directed fluid management. Descriptive statistics, univariate and multivariate statistical analyses were performed. Results: Of the 3,932 patients, 2,016 (51%) underwent laparotomy, 1,541 (39%) laparoscopy and 375 (10%) robotic approach. The incidence of thromboembolism was 0.5% (N = 21) overall, 0.8% (N = 17) with open approach and 0.2% (N = 4) with MIS approach. Among laparotomy patients, there was 88% compliance with preoperative heparin prophylaxis. Characteristics associated with developing a VTE were black race, malignancy, open surgical approach, surgical time, surgical complexity, and receipt of intraoperative blood transfusion. On multivariate analysis, black race and transfusion remained associated with VTE. Among laparotomy patients, the rate of intraoperative blood transfusion was 5.9% (N = 120), reoperation for bleeding 0.3% (N = 5) and reoperation for hematoma 0.2% (N = 3). Conclusions: We found a low rate of VTE among patients undergoing laparotomy and MIS under an ERAS pathway. The rate of VTE following MIS surgery was low without use of extended pharmacologic VTE prophylaxis or receipt of preoperative prophylactic heparin. Receipt of preoperative heparin prophylaxis prior to open surgery is safe with a low complication rate. This establishes a benchmark for the expected rate of VTE following gynecologic surgery on an ERAS pathway." @default.
• W3199265287 created "2021-09-27" @default.
• W3199265287 creator A5000098403 @default.
• W3199265287 creator A5003069434 @default.
• W3199265287 creator A5024272716 @default.
• W3199265287 creator A5024627306 @default.
• W3199265287 creator A5027456755 @default.
• W3199265287 creator A5036946380 @default.
• W3199265287 creator A5062184522 @default.
• W3199265287 creator A5064499162 @default.
• W3199265287 date "2021-10-01" @default.
• W3199265287 modified "2023-10-12" @default.
• W3199265287 title "Rate of venous thromboembolism in gynecologic patients on an ERAS pathway." @default.
• W3199265287 doi "https://doi.org/10.1200/jco.2020.39.28_suppl.214" @default.
• W3199265287 hasPublicationYear "2021" @default.
• W3199265287 type Work @default.
• W3199265287 sameAs 3199265287 @default.
• W3199265287 citedByCount "0" @default.
• W3199265287 crossrefType "journal-article" @default.
• W3199265287 hasAuthorship W3199265287A5000098403 @default.
• W3199265287 hasAuthorship W3199265287A5003069434 @default.
• W3199265287 hasAuthorship W3199265287A5024272716 @default.
• W3199265287 hasAuthorship W3199265287A5024627306 @default.
• W3199265287 hasAuthorship W3199265287A5027456755 @default.
• W3199265287 hasAuthorship W3199265287A5036946380 @default.
• W3199265287 hasAuthorship W3199265287A5062184522 @default.
• W3199265287 hasAuthorship W3199265287A5064499162 @default.
• W3199265287 hasConcept C126322002 @default.
• W3199265287 hasConcept C141071460 @default.
• W3199265287 hasConcept C2776111594 @default.
• W3199265287 hasConcept C2779399171 @default.
• W3199265287 hasConcept C2780047204 @default.
• W3199265287 hasConcept C2780435969 @default.
• W3199265287 hasConcept C2780778865 @default.
• W3199265287 hasConcept C71924100 @default.
• W3199265287 hasConceptScore W3199265287C126322002 @default.
• W3199265287 hasConceptScore W3199265287C141071460 @default.
• W3199265287 hasConceptScore W3199265287C2776111594 @default.
• W3199265287 hasConceptScore W3199265287C2779399171 @default.
• W3199265287 hasConceptScore W3199265287C2780047204 @default.
• W3199265287 hasConceptScore W3199265287C2780435969 @default.
• W3199265287 hasConceptScore W3199265287C2780778865 @default.
• W3199265287 hasConceptScore W3199265287C71924100 @default.
• W3199265287 hasIssue "28_suppl" @default.
• W3199265287 hasLocation W31992652871 @default.
• W3199265287 hasOpenAccess W3199265287 @default.
• W3199265287 hasPrimaryLocation W31992652871 @default.
• W3199265287 hasRelatedWork W10836690 @default.
• W3199265287 hasRelatedWork W14560129 @default.
• W3199265287 hasRelatedWork W18745100 @default.
• W3199265287 hasRelatedWork W21191102 @default.
• W3199265287 hasRelatedWork W21696967 @default.
• W3199265287 hasRelatedWork W21758244 @default.
• W3199265287 hasRelatedWork W43610 @default.
• W3199265287 hasRelatedWork W6072419 @default.
• W3199265287 hasRelatedWork W10597315 @default.
• W3199265287 hasRelatedWork W17604275 @default.
• W3199265287 hasVolume "39" @default.
• W3199265287 isParatext "false" @default.
• W3199265287 isRetracted "false" @default.
• W3199265287 magId "3199265287" @default.
• W3199265287 workType "article" @default.